Page 256 - Syndipharma

Type Product Dosage Form Strength Indication Status

Dopamine-reuptake Bupropion Tablet 100 mg Nervous system Available
inhibitor

Dopamine-reuptake Bupropion E.R.Tablet 150 mg Nervous system Available
inhibitor

Antidiabetic agent,
Alpha-glucosidase Acarbose Tablet 50 mg Antidiabetics Available
inhibitor

Antidiabetic agent, Sitagliptin Tablet 25 mg Antidiabetics Available IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
DPP-4 inhibitor

Antidiabetic agent, Sitagliptin Tablet 50 mg Antidiabetics Available
DPP-4 inhibitor

Antidiabetic agent, Sitagliptin Tablet 100 mg Antidiabetics Available
DPP-4 inhibitor

Antidiabetic agent, Empagliflozin* Tablet 10 mg Antidiabetics As soon as
SGLT2 inhibitors possible

Antidiabetic agent, Empagliflozin* Tablet 25 mg Antidiabetics As soon as
SGLT2 inhibitors possible

Insulin, combina- Insulin 70/30 Vial (70/30) I.U./ml Antidiabetics Available
tion Human (3ml)

Insulin, intermedi- Insulin Isophane Cartridge 100 I.U./ml (3ml) Antidiabetics Available
ate-acting Human (NPH)
Insulin, intermedi- Insulin Isophane Vial 100 I.U./ml Antidiabetics Available
ate-acting Human (NPH) (10ml)

As soon as
Insulin, long-acting Insulin Glargine* Pen 300 I.U./3 ml Antidiabetics
possible
Insulin Regular
Insulin, short-acting Cartridge 100 I.U./ml (3ml) Antidiabetics Available
Human
Insulin Regular 100 I.U./ml
Insulin, short-acting Vial Antidiabetics Available
Human (10ml)

Insulin,combination Insulin 70/30 Cartridge (70/30) I.U./ml Antidiabetics Available
(3ml)
Human
Antidiabetic agent, Metformin E.R.Tablet 500 mg Antidiabetics Available
Biguanide

Antidiabetic agent, Metformin Tablet 500 mg Antidiabetics Available
Biguanide

Systemic Hormonal Vasoperssin Ampoule 20 I.U./ml Anti-diuretic Available
Preparations hormone

Antidiabetic agent,
Alpha-glucosidase Acarbose Tablet 100 mg Antihistamines Available
inhibitor

Histamine H1 -re- Hydroxyzine Syrup 10 mg/5 ml, 120 Antihistamines Available
ceptor antagonist ml
255